No Detail Found!

Combined effects of hydralazine and nitrate on serum biochemistry and left ventricular remodeling in chronic heart failure patients

Author(s)
Wei Xu Heart Rehabilitation Center, Department of Cardiology, Shanghai Fourth People's Hospital, Tongji University,Shanghai,China
Lei Qian Heart Rehabilitation Center, Department of Cardiology, Shanghai Fourth People's Hospital, Tongji University,Shanghai,China
Xiaoyan Yuan Heart Rehabilitation Center, Department of Cardiology, Shanghai Fourth People's Hospital, Tongji University,Shanghai,China
Yong Lu Heart Rehabilitation Center, Department of Cardiology, Shanghai Fourth People's Hospital, Tongji University,Shanghai,China
Abstract
To investigate the effects of hydralazine combined with nitrate on serum levels of Adropin and brain natriuretic peptide (BNP), left ventricular remodeling and prognosis in patients with chronic heart failure (CHF). 126 CHF patients were divided into control group (n=13, sodium nitroprusside) and combined treatment group (n=63, sodium nitroprusside + hydralazine). Serum Adropin and BNP levels and left ventricular mass index (LVMI) of patients before treatment and 10 days after treatment were recorded, so did patient's end-point events. It was found that compared with those before treatment, the serum levels of Adropin, BNP, and LVMI in combined group and control group after 10 days of treatment were lower (P<0.05). The end-point event rate in the combined group was 19.05% (12/63). The serum levels of Adropin, BNP, and LVMI in the combined group with end-point events were higher than those of patients without end-point events (P<0.05). Spearman correlation analysis showed that serum levels of Adropin and BNP were positively correlated with LVMI and the end-point events rate (P<0.05). To sum up, hydralazine combined with sodium nitroprusside treatment can effectively reduce serum Adropin and BNP levels, and the risk of left ventricular remodeling and poor prognosis in patients with CHF.
Publication Details
Page(s) 381-386
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: S1, Year: 2021

Request the full text from PASTIC

Keywords
nitrate, Hydralazine, Brain natriuretic peptide, chronic heart failure, Adropin, Left Ventricular Remodeling
References
Benic GI,Eisner BM,Jung RE,Basler T,Schneider D,Hämmerle CHF D .2019 .Hard tissue changes after guided bone regeneration of peri‐implant defects comparing block versus particulate bone substitutes: 6 month results of a randomized controlled clinical trial. Clin. Oral Implants Res., 30(10) : 1016-1026.
D'Auria F,Polito MV,Vitulano G,Ciccarelli M,De Rosa R,Gigantino A,Piscione F,Galasso G F .2018 .Predictors of left ventricular reverse remodeling in patients with chronic heart failure. J. Cardiovasc. Med, 19(8) : 465-469.
Dick SA,Epelman S SA .2016 .Chronic heart failure and inflammation: What do we really know? Circ. , 119(1) : 159-176.
Díez J .2017 .Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy. Eur. J. Heart Fail, 19(2) : 167-176.
Dini FL,Capozza P,Donati F,Simioniuc A,Corciu AI,Fontanive P,Pieroni A,Di Bello V,Marzilli M .2011 .Patterns of left ventricular remodeling in chronic heart failure: prevalence and prognostic implications. Am. Heart J., 161(6) : 1088-1095.
Duan J,Chen Z,Wu Y,Zhu B,Yang L,Yang C .2019 .Metabolic remodeling induced by mitokines in heart failure. Aging (Albany NY), 11(17) : 7307-7327.
Edelmann F,Knosalla C,Mörike K,Muth C,Prien P,Störk S P .2018 .Chronic Heart Failure. Dtsch. Arztebl. Int., 115(8) : 124-130.
Ho EC,Parker JD,Austin PC,Tu JV,Wang X,Lee DS .2016 .Impact of nitrate use on survival in acute heart failure: A propensity-matched analysis. J. Am. Heart Assoc., 5(2) : e002531.
Januzzi JL,Butler J,Fombu E,Maisel A,McCague K,Piña IL,Prescott MF,Riebman JB,Solomon S JB .2018 .Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF). Am Heart J., 199 : 130-136.
Januzzi JL,Ahmad T,Mulder H,Coles A,Anstrom KJ,Adams KF,Ezekowitz JA,Fiuzat M,Houston-Miller N,Mark DB,Piña IL,Passmore G,Whellan DJ,Cooper LS,Leifer ES,Desvigne-Nickens P,Felker GM,O'Connor CM .2019 .Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol., 74(9) : 1205-1217.
Kalkan AK,Cakmak HA,Erturk M,Kalkan KE,Uzun F,Tasbulak O,Diker VO,Aydin S,Celik A .2018 .Adropin and irisin in patients with cardiac cachexia. Arq Bras Cardiol., 111(1) : 39-47.
Khanam SS,Son JW,Lee JW,Youn YJ,Yoon J,Lee SH,Kim JY,Ahn SG,Ahn MS,Yoo BS .2017 .Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure. BMC Cardiovasc, 17(1) : 215.
Ky B,French B,May Khan A,Plappert T,Wang A,Chirinos JA,Fang JC,Sweitzer NK,Borlaug BA,Kass DA,St John Sutton M and Cappola TP DA .2013 .Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure. J Am Coll Cardiol., 62(13) : 1165-1172.
Lim HC,Wiedemeier DB,Hämmerle CHF,Thoma DS .2019 .The amount of keratinized mucosa may not influence peri-implant health in compliant patients: A retrospective 5-year analysis. J. Clin. Periodontol, 46(3) : 354-362.
Mayama M,Yoshihara M,Uno K,Tano S,Takeda T,Ukai M,Kishigami Y,Oguchi H Y .2017 .Factors influencing brain natriuretic peptide levels in healthy pregnant women. Int. J. Cardiol., 228 : 749-753.
Motiwala SR,Szymonifka J,Belcher A,Weiner RB,Baggish AL,Gaggin HK,Bhardwaj A,Januzzi JL .2014 .Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling. J Cardiovasc Transl Res., 7(2) : 250-261.
Naenni N,Lim HC,Papageorgiou SN,Hämmerle CHF .2019 .Efficacy of lateral bone augmentation prior to implant placement: A systematic review and meta-analysis. J. Clin. Periodontol, 46(Suppl 21) : 287-306.
Nakagawa Y,Nishikimi T,Kuwahara K .2019 .Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides., 111 : 18-25.
Radovanovic S,Savic-Radojevic A,Pekmezovic T,Markovic O,Memon L,Jelic S,Simic D,Radic T,Pljesa-Ercegovac M,Simic T .2014 .Uric acid and gamma-glutamyl transferase activity are associated with left ventricular remodeling indices in patients with chronic heart failure. Rev. Esp. Cardiol, 67(8) : 632-642.
Sabry DA,Cordeiro SL,Ferreira Silva CH,Cunha Farias EH,Sassaki GL,Nader HB,Oliveira Rocha HA .2019 .Pharmacological prospection and structural characterization of two purified sulfated and pyruvylated homogalactans from green algae Codium isthmocladum. , 222 : 115010.
Salvador AM,Nevers T,Velázquez F,Aronovitz M,Wang B,Abadía Molina A,Jaffe IZ,Karas RH,Blanton RM,Alcaide P .2016 .Intercellular adhesion molecule 1 regulates left ventricular leukocyte infiltration, cardiac remodeling, and function in pressure overload-induced heart failure. J. Am. Heart Assoc., 5(3) : e003126.
Tham YK,Bernardo BC,Ooi JY,Weeks KL,McMullen JR .2015 .Pathophysiology of cardiac hypertrophy and heart failure: Signaling pathways and novel therapeutic targets. Arch. Toxicol., 89(9) : 1401-1438.
Uriel N,Sayer G,Annamalai S,Kapur NK,Burkhoff D NK .2018 .Mechanical unloading in heart failure. J. Am. Coll. Cardiol., 72(5) : 569-580.
Yosaee S,Soltani S,Sekhavati E,Jazayeri S .2016 .Adropin: A novel biomarker of heart disease: A systematic review article. Iran J. Public Health, 5(12) : 1568-1576.
Ypenburg C,Bommel RJ,Borleffs CJ,Bleeker GB,Boersma E,Schalij MJ,Bax JJ .2009 .). Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol., 53(6) : 483-490.
Zhang L,Tang F,Cai LP,Wang HL,Wang Z HL .2017 .Research on the correlation of urine calcium integrin binding protein-1 and pro-BNP with ischemic heart failure. Eur. Rev. Med, 21(18) : 4181-4185.
0

Citations

0

Downloads

11

Views